Hepatitis A – Creating a Market for Another Superfluous Vaccine

They finally did it. After years of lobbying and angling, GlaxoSmithKline finally got their new vaccine for Hepatitis A tacked onto the mandated schedule as of Jan 2002, with no public fanfare. (www.aap.org) The vaccine is called Havrix, and is delineated on p.1544 of...